Who
Michael Gilman
Director
Company insider
Files Form 4 as: Director, Scholar Rock Holding; Director, EPIX Pharmaceuticals.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $1.0M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 24 Apr 2006
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $72K1,346 at $53.54 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $63K1,155 at $54.23 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $2,35743 at $54.81 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $72K1,346 at $53.54 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $63K1,155 at $54.23 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $2,35743 at $54.81 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code A | —6,839 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,310 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,310 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code A | —6,839 at $0.00 | filing |
| 29 May 2025filed 30 May 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $18K630 at $29.22 | filing |
| 29 May 2025filed 30 May 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $82K2,745 at $29.83 | filing |
| 22 May 2025filed 23 May 2025 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,206 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code A | —7,632 at $0.00 | filing |
| 12 Nov 2024filed 13 Nov 2024 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code G | —37,459 | filing |
| 12 Nov 2024filed 13 Nov 2024 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code G | —37,459 | filing |
| 27 Jun 2024filed 1 Jul 2024 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 27 Jun 2024filed 1 Jul 2024 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 21 Jun 2023filed 22 Jun 2023 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 8 Jul 2022filed 12 Jul 2022 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code G | —37,459 | filing |
News
Scholar Rock Resubmits Marketing Authorisation Application For ApitegromabSRRK · rttnews.com · 8 Oct 2026
0 headlines in the last 90 days name Michael Gilman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.